RN

Rajendra Nath Srivastava

Active Director Director DIN 00767377
DIN 00767377 First appointment Sep 2005 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajendra Nath Srivastava

Data last updated:

Rajendra Nath Srivastava is a Director at Clintech Research India Private Limited (since 2005). The company operates in Professional Services.

DIN 00767377
Primary Designation Director
Industry Professional Services
First Appointment 15 Sep 2005
Oldest Company Age 21 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Sep 20052005Under Process Of Striking Off

Board colleagues of Rajendra Nath Srivastava

Directorship timeline

Open interactive timeline →
Clintech Research India Private Limited
Premium access

Shareholding and investment profile for Rajendra Nath Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Nath Srivastava

Rajendra Nath Srivastava currently holds 1 directorship: Clintech Research India Private Limited (Director, since 15 Sep 2005).

Rajendra Nath Srivastava was first appointed on 15 Sep 2005 as Director at Clintech Research India Private Limited.

The current boards of Rajendra Nath Srivastava's companies include Avinash Kumar Srivastava (Clintech Research India Private Limited), Sri Prakash Srivastava (Clintech Research India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available